Skip to main content
ABION Inc. logo

ABION Inc. — Investor Relations & Filings

Ticker · 203400 ISIN · KR7203400007 KO Professional, scientific and technical activities
Open in API
Filings indexed 409 across all filing types
Latest filing 2019-10-10 Regulatory Filings
Country KR South Korea
Listing KO 203400

About ABION Inc.

https://abionbio.com/en/

ABION Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative medicines, focusing on first-in-class and best-in-class therapeutics for oncology and viral diseases. The company's lead oncology asset is ABN401, a selective c-Met tyrosine kinase inhibitor (TKI) designed to treat non-small cell lung cancer (NSCLC) with MET mutations, which has shown a favorable safety profile. Another key pipeline candidate is ABN501, a novel monoclonal antibody targeting Claudin-3 for various cancers. Beyond oncology, ABION is developing ABN101, a second-generation Interferon-β formulated as a broad-spectrum anti-viral inhaler for respiratory infections. The company aims to commercialize its assets in global markets through internationally recognized clinical processes.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, time, location, and purpose of the meeting, and explicitly states that the actual IR materials will be distributed on the day of the event. Since this is an announcement of an event rather than the presentation materials themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a formal notice to the market.
2019-10-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used when an executive or major shareholder reports their holdings or changes in holdings of company securities. This falls under the category of 'Director's Dealing' (DIRS) as it details personal share transactions and holdings by a company executive (in this case, Choi Jun Young, a Vice President).
2019-09-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea for reporting insider transactions, share acquisitions, and changes in ownership by company directors or major shareholders. Based on the provided filing categories, this corresponds to 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2019-09-09 Korean
전환가액의조정(제7회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price of convertible bonds (or preferred shares) for the company 'Abion'. It details the specific changes to the conversion price, the number of convertible shares, the calculation methodology based on market price fluctuations, and the effective date. This type of disclosure regarding capital structure changes, specifically the adjustment of conversion prices for financial instruments, falls under the 'Capital/Financing Update' category.
2019-08-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form used in South Korea (often referred to as the 'Insider Trading Report' or 'Director's Dealing' report) to notify the regulatory authorities (Financial Services Commission and Korea Exchange) of changes in share ownership by company insiders. Based on the provided categories, this aligns with 'Director's Dealing' (DIRS).
2019-08-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a standard regulatory filing in South Korea (DART system) used to disclose insider shareholdings and changes in ownership by directors or major shareholders. Based on the provided categories, this falls under 'Director's Dealing' (DIRS), as it reports the personal share transactions and ownership status of a company director (사내이사 강진우).
2019-08-30 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.